PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 12 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,669,000 | +0.2% | 2,500,000 | 0.0% | 0.13% | +6.8% |
| Q2 2016 | $1,666,000 | -1.7% | 2,500,000 | 0.0% | 0.12% | -3.3% |
| Q1 2016 | $1,694,000 | -1.5% | 2,500,000 | 0.0% | 0.12% | -4.7% |
| Q4 2015 | $1,720,000 | -3.4% | 2,500,000 | 0.0% | 0.13% | -0.8% |
| Q3 2015 | $1,780,000 | -5.7% | 2,500,000 | 0.0% | 0.13% | +21.7% |
| Q2 2015 | $1,888,000 | +1.2% | 2,500,000 | 0.0% | 0.11% | +14.0% |
| Q1 2015 | $1,866,000 | -1.2% | 2,500,000 | 0.0% | 0.09% | +1.1% |
| Q4 2014 | $1,889,000 | – | 2,500,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 4,000,000 | $3,200,000 | 2.53% |
| Mohican Financial Management, LLC | 2,600,000 | $1,965,000 | 0.97% |
| Camber Capital Management LP | 9,000,000 | $6,904,000 | 0.46% |
| LINDEN ADVISORS LP | 2,000,000 | $1,519,000 | 0.29% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 16,772,000 | $12,674,000 | 0.16% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,000,000 | $8,635,000,000 | 0.15% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,900,000 | $5,442,000 | 0.11% |
| ANGELO GORDON & CO., L.P. | 2,500,000 | $1,889,000 | 0.09% |
| Baker Brothers Advisors | 3,500,000 | $2,645,000 | 0.03% |
| FEDERATED HERMES, INC. | 5,330,000 | $4,040,000 | 0.01% |